MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis. - sprookjes - yvandenbroek - TriplyDB

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

http://www.wikidata.org/entity/Q34602737

about

Impact of MDM2 309T>G polymorphism on sarcomagenesis Association between murine double minute 2 T309G polymorphism and risk of liver cancer.A 40-bp insertion/deletion polymorphism of Murine Double Minute2 (MDM2) increased the risk of breast cancer in Zahedan, Southeast Iran.A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.Polymorphisms in the MDM2 gene and risk of malignant bone tumors: a meta-analysis.MDM2 SNP309T>G polymorphism and hepatocellular carcinoma risk: a meta-analysis.Analysis of 12 variants in the development of gastric and colorectal cancers.Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population.Association of the recurrence of vocal leukoplakia with MDM2-309 variants over a 2-year period: a prospective study.

P2860

Q28608667-1A2C3BC0-09B0-46A8-94CA-6AEF82516DBC Q34433411-ED5DE731-912F-4785-9C21-CAC9ACF7F1FC Q34475865-E2489891-D85A-47A5-928A-9630227E29F4 Q35218636-389E0908-4B63-4CB1-9C8D-7A0534602477 Q44820188-BA108F86-5F00-496A-BE6A-0A2433B17D92 Q46761401-52340DBC-38C3-467A-B832-E60B8CF13317 Q49658071-CE92ED86-1217-4907-A412-60BDB8582BBE Q53226854-9A5AB6C8-B0B0-47D2-91A9-D34960CCDD09 Q53350556-83463A27-6C25-4502-8EDB-4D8B59B5F6E9

P2860

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

http://www.wikidata.org/entity/Q34602737

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

@ast

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

@en

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

@nl

type

label

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

@ast

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

@en

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

@nl

prefLabel

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

@ast

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

@en

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

@nl

P1433

Q34602737-FF29859D-7B84-4DE0-B303-11D6FC751040

P1476

Q34602737-F26C26A7-D973-4F78-A4B5-E3FE08096EF7

P2093

Q34602737-14B9D510-0F06-465E-B8B6-E7D820ADA88B

Q34602737-5C11CD2A-7D86-41D2-852B-4F365E8497FB

Q34602737-623D0E31-17A5-4861-B6D4-B814AB831D2E

P2860

Q34602737-1F6E7415-B401-45DC-8FC9-DE8879DC399A

Q34602737-26679FA1-F053-4082-9FC6-A2ED4EDF65D5

Q34602737-368E11B1-2F74-47A7-99B8-0007A2E60E5B

Q34602737-3697A9A6-E325-4B3F-9279-64AD845FE34E

Q34602737-43FBC3E9-AA87-4D02-8636-FF976BE3C4BC

Q34602737-613F1F91-6CBD-4DE7-9B8D-BCC69A6FA5C3

Q34602737-8BE4C15D-AFC0-4D31-A118-AC46B82BA0EB

Q34602737-9D79F708-F138-40C0-B28D-3FDD42A00CCC

Q34602737-A64DE1D3-6CBA-45CD-88A8-E3DB252951C5

Q34602737-A8D63C31-DA11-4CD0-8227-69C0CB27A082

P304

Q34602737-F13DF479-B0C8-46DC-A34E-061CE647E862

P31

Q34602737-16ddbad9-f32d-4883-a9c6-6d060de29044

Q34602737-2250DC2D-9BC3-48EA-AA52-F8C0125A837A

P356

Q34602737-0C846467-F17B-46CF-A782-1E64ECB34E13

P407

Q34602737-A3000E61-C2AF-4351-AC7D-7FC198B58AEB

P433

Q34602737-3C90F759-BB6A-4519-A074-7CADF2EB9DA7

P478

Q34602737-57F42B5A-438F-4720-8944-7145B61A1DD0

P577

Q34602737-2C91BEA4-9699-45FF-A853-E3DC1149D636

P5875

Q34602737-2F3ACE7A-E356-4728-87E5-EB7FCE35469A

P698

Q34602737-0077311F-7589-409B-8E7A-AF68F8BA5879

P932

Q34602737-6B39571A-C72C-4D59-96EE-997E7B14F97A

P356

JOURNAL.PONE.0056918

P1433

P1476

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

@en

P2093

Hongyong Cao

http://www.w3.org/2001/XMLSchema#string

Jianmin Bian

http://www.w3.org/2001/XMLSchema#string

Yong Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Mdm2 promotes the rapid degradation of p53

Cancer statistics, 2010

The MDM2-p53 interaction.

Genetic susceptibility and gastric cancer risk.

TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.

Epidemiology of upper gastrointestinal malignancies.

A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect.

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

Adenocarcinomas of the esophagus and gastric cardia: the role of diet.

Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.

P304

e56918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0056918

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235757848

http://www.w3.org/2001/XMLSchema#string

P698

23451111

http://www.w3.org/2001/XMLSchema#string

P932

3581579

http://www.w3.org/2001/XMLSchema#string